SYNERGY BIOLOGICS LIMITEDActive
Key figures
Like most small UK companies, SYNERGY BIOLOGICS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 1,736,109 | 1,047,091 | 760,432 | 245,373 | 426,060 |
| Total assets | 4,887,529 | 4,766,537 | 4,252,338 | 4,128,286 | 4,262,388 |
| Total liabilities | — | — | — | — | — |
| Net assets / total equity | 3,451,848 | 3,856,761 | 3,778,330 | 3,860,650 | 3,791,465 |
| Average number of employees | 27 | 22 | 0 | 17 | 19 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: SYNERGY BIOLOGICS LIMITED
Company
SYNERGY BIOLOGICS LIMITED is a private limited company registered with Companies House under company number 07353610. It was incorporated on 23 Aug 2010. Its status is active. The registered office is in Walsall (WS1). Its nature of business (SIC 2007) is manufacture of basic pharmaceutical products (21100).
Accounts
The latest accounts in the database are for 2024/25 (period ending 30 Apr 2025); the company files small company accounts (filleted). Net assets were £3,791,465, down 1.8% on the previous year. Cash at bank and in hand was £426,060. The company had an average of 19 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 31 Jan 2027. The next confirmation statement is due by 6 Sep 2027.